openPR Logo
Press release

Latest Study: Cholera Vaccine Market is expanding at $207 Million by 2025 with growing CAGR | Hospitals & Clinics Segment is fastest growth rates

04-04-2019 01:12 PM CET | Health & Medicine

Press release from: Allied Market Research

Cholera Vaccine Market

Cholera Vaccine Market

The global cholera vaccine market was valued $65 Million in 2017, and is projected to reach $207 Million by 2025, with a growing CAGR of 15.6% during forecast period 2018 to 2025.

A vaccine is a biological preparation that assists in strengthening the immune system and provides acquired immunity against a specific pathogen. Vaccinations have proved to be one of the best methods to treat infectious diseases by many international organizations such as the World Health Organization (WHO). Cholera is one of the type of infectious disease caused by the bacterium Vibrio cholera. It is associated with the severe diarrhea and the immediate treatment is essential as death is inevitable if the disease is left untreated.

Cholera is anticipated to be a global threat to public health especially in regions that lack social development. Thus, cholera vaccine is essential to control cholera. There are two types of cholera vaccine available in the market including inactivated and live oral cholera vaccines, whereas inactivated cholera vaccines are successfully employed globally. These vaccines are mainly taken by travelers and the people who are living in the cholera affected region. In addition, WHO is recommended that cholera vaccine should be taken at least 2 weeks before arrival at the destination and at least 1 week of gap between the doses. Hence, these aforementioned factors helps in increasing the global cholera vaccine market share.

Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/5177?utm_source=opr_sank

Key Findings Of The Global Cholera Vaccine Market Study:

• Based on product, the Vaxchora segment is expected to experience rapid growth in the market, and is projected to grow at a CAGR of 17.4% from 2018 to 2025.
• Depending on end user, the pharmaceutical & biotechnology companies segment is expected to exhibit the highest CAGR during the forecast period.
• U.S. generated the highest revenue in the global cholera vaccine market industry in 2017, accounting less than one-tenth of the global market in 2017.
• North America is estimated to grow at a CAGR of 17.1% during the forecast period.

The Dukoral segment accounted around half of the total market share in 2017.

The cholera vaccine market is expected to exhibit significant growth during the forecast period due to lack of proper sanitation & consumption of contaminated food and growth in awareness about cholera preventive care. In addition, development of novel approaches for new cholera vaccine further drive the market growth. However, risk of adverse effects and the time taken for the regulatory approval is projected to impede the market growth. On the contrary, high growth opportunities in untapped markets are expected to offer significant profitable opportunities for the market players in the near future.

Based on end user, the market is categorized into hospitals & clinics, research & academic laboratories, and others. The hospitals & clinics segment presently dominates the market, and is expected to remain dominant during the forecast period. This is attributed to the fact that hospitals and clinics are authorized to organize campaigns for cholera vaccination, as the number of cases for cholera diseases is rapidly growing in LMICs.

Asia-Pacific was the leading revenue contributor to the global cholera vaccine market in 2017, and is expected to remain dominant throughout the forecast period due to increase in the prevalence of cholera disease and rise in importance of immunization. However, North America is expected to grow at the highest CAGR during the study period. This is attributed to the launch of the first and only oral cholera vaccine, Vaxchora, in the USA. Furthermore, the number of travelers to the cholera-affected countries is increasing, which in turn increases the demand for immunization.

The report provides a comprehensive analysis of the key players operating in the global cholera vaccine market industry, namely Valneva SE, Emergent BioSolutions, Inc. (PaxVax, Inc.), Astellas Pharma, Inc., Sanofi (Shantha Biotechnics Private Limited), Eubiologics Co., Ltd., and Johnson & Johnson (Crucell), Celldex Therapeutics, Inc. The other players in the in the cholera vaccine market industry include Merck & Co., Inc., GlaxoSmithKline plc., and others.

Flat 20% Discount on All License Type.. https://www.alliedmarketresearch.com/checkout/309046
*Offer Valid Till 20th April 2019

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client's insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Latest Study: Cholera Vaccine Market is expanding at $207 Million by 2025 with growing CAGR | Hospitals & Clinics Segment is fastest growth rates here

News-ID: 1688083 • Views: 212

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Cholera

Global Cholera Vaccines Market Review 2018-2023 Merck, PaxVax, Valneva
A market study "Global Cholera Vaccines Market" examines the performance of the Cholera Vaccines market 2018. It encloses an in-depth Research of the Cholera Vaccines market state and the competitive landscape globally. This report analyzes the potential of Cholera Vaccines market in the present and the future prospects from various angles in detail. The Global Cholera Vaccines Market 2018 report includes Cholera Vaccines market Revenue, market Share, Cholera Vaccines industry volume,
Cholera Vaccine Market to Record High Demand by 2017 - 2022
- YEAR END BONANZA - Flat 20% discount on purchase of reports from 1st December to 31st December. https://www.researchtrades.com/discount/1321615 * Terms & Conditions apply!! Contact No. : +16269994607 (US), /+91 7507349866 (IND) Email: sales@researchtrades.com Report Overview: The “Global Cholera Vaccine Market Research Report” is a professional and in-depth study on the current state of the Cholera Vaccine Market. The study offers an insight into current and future market trends, key drivers and restraints, market strategies of
Cholera Vaccine Market Expecting an Outstanding Growth Till 2022
QY Research Groups’ expert research analysts estimate the Cholera Vaccine Market to grow at a substantial Compound Annual Growth Rate (CAGR) throughout the forecast period 2017 to 2022. The report ‘Global Cholera Vaccine Market Research Report 2017’ centers on essential expertise of Global Cholera Vaccine segment. The potential of the segment has been examined along with the key challenges. The current market scenario and the future prognosis of the segment has
Cholera Treatment Market - Detailed Study Analysis and Forecast by 2024
Cholera disease spreads because of contamination of water and food and is closely associated with poor sanitation and lack of clean drinking water. The global disease burden is around 3–5 million cases and 100 000– 130 000 deaths per year. In recent time the frequency of cholera epidemics has increased. The disease is caused by Vibrio cholerae a rod-shaped waterborne bacterium. The toxins released by bacterium causes loss of intravascular
Cholera Treatment Market Growth Report 2016- 2024
Cholera disease spreads because of contamination of water and food and is closely associated with poor sanitation and lack of clean drinking water. The global disease burden is around 3–5 million cases and 100 000– 130 000 deaths per year. In recent time the frequency of cholera epidemics has increased. The disease is caused by Vibrio cholerae a rod-shaped waterborne bacterium. The toxins released by bacterium causes loss of intravascular
Cholera Treatment Market: Brand Analysis and Forecast upto 2024
Cholera disease spreads because of contamination of water and food and is closely associated with poor sanitation and lack of clean drinking water. The global disease burden is around 3–5 million cases and 100 000– 130 000 deaths per year. In recent time the frequency of cholera epidemics has increased. The disease is caused by Vibrio cholerae a rod-shaped waterborne bacterium. The toxins released by bacterium causes loss of intravascular